GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (MIL:1AFX) » Definitions » COGS-to-Revenue

Carl Zeiss Meditec AG (MIL:1AFX) COGS-to-Revenue : 0.50 (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Carl Zeiss Meditec AG COGS-to-Revenue?

Carl Zeiss Meditec AG's Cost of Goods Sold for the three months ended in Sep. 2024 was €289 Mil. Its Revenue for the three months ended in Sep. 2024 was €580 Mil.

Carl Zeiss Meditec AG's COGS to Revenue for the three months ended in Sep. 2024 was 0.50.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Carl Zeiss Meditec AG's Gross Margin % for the three months ended in Sep. 2024 was 50.05%.

Carl Zeiss Meditec AG COGS-to-Revenue Historical Data

The historical data trend for Carl Zeiss Meditec AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG COGS-to-Revenue Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.41 0.41 0.42 0.47

Carl Zeiss Meditec AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.47 0.47 0.46 0.50

Carl Zeiss Meditec AG COGS-to-Revenue Calculation

Carl Zeiss Meditec AG's COGS to Revenue for the fiscal year that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=977.497 / 2066.127
=0.47

Carl Zeiss Meditec AG's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=289.497 / 579.627
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG  (MIL:1AFX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Carl Zeiss Meditec AG's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 289.497 / 579.627
=50.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Carl Zeiss Meditec AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Carl Zeiss Meditec AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (MIL:1AFX) » Definitions » COGS-to-Revenue
Comparable Companies
XTER:1SXP XTER:FIE XTER:GXI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST COO XSWX:STMN HOLX TSE:7733 XPAR:DIM BAX ALGN AVTR
Traded in Other Exchanges
CZMWY:USA CZMWF:USA AFXd:UK 0DHC:UK AFX:Germany AFX:Austria
Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Website
https://www.zeiss.com
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG Headlines

No Headlines